title: Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
abstract: Pseudomonas aeruginosa causes chronic infections in the lungs of cystic fibrosis (CF) individuals and remains the leading cause of morbidity and mortality associated with the disease. Biofilm growth and phenotypic diversification are factors thought to contribute to this organism's persistence. Most studies have focused on laboratory isolates such as strain PAO1, and there are relatively few reports characterizing the properties of CF strains, especially under decreased oxygen conditions such as occur in the CF lung. This study compared the phenotypic and functional properties of P. aeruginosa from chronically infected CF adults with those of strain PAO1 and other clinical non-CF isolates under aerobic and anaerobic culture conditions. The CF isolates overall displayed a reduced ability to form biofilms in standard in vitro short-term models. They also grew more slowly in culture, and exhibited decreased adherence to glass and decreased motilities (swimming, swarming and twitching). All of these characteristics were markedly accentuated by anaerobic growth conditions. Moreover, the CF strain phenotypes were not readily reversed by culture manipulations designed to encourage planktonic growth. The CF strains were thus inherently different from strain PAO1 and most of the other non-CF clinical P. aeruginosa isolates tested. In vitro models used to research CF isolate biofilm growth need to take the above properties of these strains into account.
authors.affiliation: School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
authors.forename: Che Y
authors.initials: CY
authors.lastname: O'May
authors.forename: David W
authors.initials: DW
authors.lastname: Reid
authors.forename: Sylvia M
authors.initials: SM
authors.lastname: Kirov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000693:Anaerobiosis / Q000502:physiology*; D018441:Biofilms / Q000254:growth & development*; D003550:Cystic Fibrosis / Q000382:microbiology*; D006801:Humans; D007223:Infant; D010641:Phenotype; D011552:Pseudomonas Infections / Q000209:etiology / Q000503:physiopathology*; D011550:Pseudomonas aeruginosa / Q000254:growth & development / Q000302:isolation & purification / Q000472:pathogenicity*; D013183:Sputum / Q000382:microbiology*